COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > HEP phenomenology joint Cavendish-DAMTP seminar > Standard Candle Central Exclusive Processes at Hadron Colliders
Standard Candle Central Exclusive Processes at Hadron CollidersAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Steve Chun Hay Kom. Central exclusive production (CEP) processes in high-energy proton – (anti)proton collisions offer a very promising framework within which to study both novel aspects of QCD and new physics signals. Among the many interesting processes that can be studied in this way, those involving the production of heavy (c, b) quarkonia and diphoton states have sufficiently well understood theoretical properties and sufficiently large cross sections that they can serve as ‘standard candle’ processes with which we can benchmark predictions for new physics CEP at the CERN Large Hadron Collider. In this talk I give an overview of the basic theoretical formalism used to describe CEP processes and, motivated by the broad agreement with theoretical predictions of recent CEP measurements at the Fermilab Tevatron, discuss and give predictions for heavy quarkonia and diphoton exclusive production at the Tevatron, RHIC and LHC . The results confirm the rich phenomenology that these production processes offer at present and future high-energy colliders. This talk is part of the HEP phenomenology joint Cavendish-DAMTP seminar series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCambridge Social Ontology Group (CSOG) Jesus College Graduate Society Graduates' and Fellows' Symposia Machine Learning Reading GroupOther talksAsclepiadaceae Short-Selling Restrictions and Returns: a Natural Experiment The Partition of India and Migration The frequency of ‘America’ in America Single Cell Seminars (September) Black and British Migration Validation & testing of novel therapeutic targets to treat osteosarcoma Computing High Resolution Health(care) Malaria’s Time Keeping |